Portfolio Strategies (Washington)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$12K Hold
200
0.02% 50
2017
Q3
$13K Hold
200
0.02% 37
2017
Q2
$11K Hold
200
0.02% 47
2017
Q1
$11K Hold
200
0.01% 43
2016
Q4
$12K Buy
+200
New +$10.9K 0.01% 53

Other funds holding BMY

Portfolio Strategies (Washington)'s BMY Position: Q4 2017 in Review

Portfolio Strategies (Washington) held its Bristol-Myers Squibb (BMY) position steady in Q4 2017 at 200 shares worth $12K. The position accounts for 0.02% of the portfolio, ranked #50.

Portfolio Strategies (Washington) first reported a position in BMY in Q4 2016 and has held it in 5 quarters since. The position peaked at $13K in Q3 2017. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • Portfolio Strategies (Washington) held 200 shares of Bristol-Myers Squibb worth $12K as of Q4 2017.
  • Portfolio Strategies (Washington) left its Bristol-Myers Squibb share count unchanged in Q4 2017.
  • Bristol-Myers Squibb made up 0.02% of Portfolio Strategies (Washington)'s portfolio in Q4 2017, its #50 holding.
  • Portfolio Strategies (Washington) first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 5 quarters since.
  • Portfolio Strategies (Washington)'s Bristol-Myers Squibb position peaked at $13K in Q3 2017.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Portfolio Strategies (Washington)'s 13F filing for Q4 2017, filed 13 Feb 2018.